Aspen Aerogels (ASPN) is expected to deliver powerful revenue growth during 2020, and the market estimates it will be growing enviously in the following years.
Investing in the company presents a sheltered risk-reward proposition with a dream come true downside and powerful upside potential, as it reaches profitability, its price will skyrocket.
In the last article, I questioned whether the company would be able to improve its gross margin significantly, as we hadn´t seen concrete evidence on the progress. But last quarter results were the key to jump into the stock.